Delivery Order SPE2DX22D0010-SPE2D824FLK85

Award Date 4/4/24
Potential Completion Date 4/5/24
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of dextroamphetamine extended-release capsules. The contract is a Delivery Order with a Firm Fixed Price of $1,535.11 and a completion date of June 14, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,809.93 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,464,709 units of 15 mg dextroamphetamine extended-release capsules. The contract has a performance period through May 2, 2024. This delivery order is part of Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,084.38 Firm Fixed Price delivery order covers the supply of Dextroamphetamine Extended-Release Capsules, 10mg. The award is a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of dextroamphetamine extended-release capsules. The award, valued at $1,830.77, is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor for this...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,316.40, is for the delivery of dextroamphetamine extended-release capsules (10mg). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 through December 2025. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,329.62 firm fixed-price delivery order is for the supply of 4,566,407,543 units of dextroamphetamine-amphetamine extended-release 25 mg capsules. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order for the supply of 10 mg Dextroamphetamine-Amphetamine capsules. The award, valued at $3,465.94, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency under the Department of Defense. This delivery order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug...
This federal contract award, valued at $1,047.72, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) within the Department of Defense (DoD). The award was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of 20 mg capsules of the prescription drug dextroamphetamine-amphetamine, with an ultimate completion date of May 15, 2024. This is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,449.40 firm fixed-price delivery order is for the supply of 4,562,967,887 units of Dextroamphetamine ER 10 mg capsules. The award has an ultimate completion date of December 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract, valued at up to $2,681.93, is for the delivery of 4,565,151,422 units of 10mg dextroamphetamine tablets. This is a...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FLK85
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,162.63 firm fixed price delivery order is for the supply of 10mg dextroamphetamine extended-release capsules.

The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Generated 7/4/24, 9:07 AM